Trial intelligence / Profile preview

Erector spinae plane block versus paravertebral block for rib fracture analgesia

ACTRN12618001786280Phase 4Not yet recruiting

Sponsor
Royal Brisbane and Women's Hospital
Start
Dec 2018
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of ropivacaine in rib fracture (2 arms), sponsored by Royal Brisbane and Women's Hospital. Primary endpoints: Verbal pain score, Opioid dose used and 1 more. Planned start Dec 2018; status: not yet recruiting.

02

Drugs

ropivacaine
03

Conditions

rib fracture

Beyond the preview

Go deeper on ACTRN12618001786280.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12618001786280.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call